Dolphins Cancer Challenge
Where the Money Goes Where the Money Goes

“Now more than ever, the funds we raise through the DCC can impact the lives of our friends and family members who are struggling to overcome cancer”.

– DR. STEPHEN D. NIMER, director of Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine

___________________________________________________________________

100% of the funds raised by the riders in the DCC are used to support cancer research at the University of Miami Sylvester Comprehensive Cancer Center. These funds stay right here in South Florida to improve the lives of cancer patients and their families. Because our patients come from throughout the region, (23% from Palm Beach County, 22% from Broward County, and 45% from Miami-Dade), the impact is felt across all three counties where the ride takes place.

Dr. Stephen Nimer and his leadership team make a special effort to prioritize the use of the funds where they will have the most impact today and into the future.  With this as the goal, the DCC funds are used to:

Nearly all of Sylvester’s senior leaders, and many of the physicians and scientists who receive support for their research, ride on Team UM Sylvester. Together, we are building a world-class cancer center!

Translational Research 13% – Identifying novel cancer therapies with a special focus on developing precision treatment efforts.

Clinical Trials 20% – Conducting clinical trials will allow patients to receive some of the most promising new drugs being developed.

Among the most urgent needs:

Pediatric Oncology 20% – Improving cancer treatment for children.

Breast Cancer 11% – Better understand the heterogeneity of breast cancer to help deliver more personalized therapies.

Genitourinary Cancer 5% – Identifying the causes of kidney cancer.

Radiation Oncology Research 31% – Developing new ways to more precisely deliver radiation therapy in prostate and bladder cancers.

The following examples outline projects and programs where DCC funds have been used since its inception in 2010.

Pediatric Oncology

Targeted Therapy

Radiation Oncology

Stem Cell/Epigenetics

Creation of the DCC Endowment Fund 

Specific Examples

Dr. Alan Pollack, M.D., Ph.D.

Dr. Tan Ince

Dr. Adrian Ishkanian

Dr. Xiao-Jian Sun, PhD

Funds raised since 2010
INAUGURAL RIDE:
$11,550,000
Funds Raised for DCC VI:

$53,601.00
DCC VI Participants:

495
COUNTDOWN TO DCC VI:

DAYS